Brief: EQL Pharma Q3 EBIT Rises To SEK 2.4 Million
18/02/2021 13:45
Feb 18 (Reuters) - EQL Pharma AB EQL.TE :
* INTERIM REPORT APRIL - DECEMBER 2020
* CONSOLIDATED SALES DURING Q3 AMOUNTED TO SEK 29.6 (20.9)
MILLION, AN INCREASE OF 41%
* OCT-DEC EBIT FOR QUARTER WAS SEK 2.4 (1.6) MILLION.
Source text for Eikon: ID:nWkr7P5hHj
Further company coverage: EQL.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))